OptiBiotix Health PLC (LON:OPTI) said its agreement with Draco Ingredients has been extended to include a second product.
As well as distributing weight management line SlimBiome in Germany, it is adding to the roster WellBiome, developed to promote gut health.
“The introduction of WellBiome gives us the opportunity to extend our product portfolio of functional ingredients with scientifically proven benefits and increase the commercial opportunity,” Andre Wittke, Draco’s general manager said in a statement.
“There is growing awareness of the link between gut health and general wellbeing in Germany and WellBiome creates a ‘ready for market’ opportunity to access this growing health and wellbeing trend,” he added.
OptiBiotix is a specialist in the human microbiome, the ecosystem of bacteria that resides in the gut and on the skin.
Its new approach to wellbeing has seen it develop compounds to tackle obesity, high cholesterol and diabetes.
The Draco deal is one in a growing line of commercial tie-ups that has seen the international roll-out of products.